NCT06268301View on ClinicalTrials.gov

A Study to Determine the Effect Food Has on TAK-721 (Budesonide Oral Suspension) in the Body of Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 6, 2023

Primary Completion Date

February 17, 2023

Study Completion Date

February 20, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

Budesonide

Budesonide oral suspension

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY